Paper Review Records
All Paper Review Records
10 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.
54
days
Lower glucagon response and attenuated hepatic glucagon signaling in MASLD
AuthorsSo Ra Kim; Yeseong Hwang; Minyoung Lee; Arim Choi; Byung-Wan Lee; Eun Seok Kang; Bong-Soo Cha; Kwang Joon Kim; Yong-ho Lee
AffiliationsDepartment of Internal Medicine, Institute of Endocrine Research, Yonsei University College of Medicine, 50–1 Yonsei–ro, Seodaemun–gu, Seoul, 03722, Republic of Korea; Department of Internal Medicine, CHA Bundang Medical Center, CHA University School of Medicine, 59 Yatap-ro, Bundang-gu, Seongnam, Gyeonggi-do, 13496, Republic of Korea; Division of Geriatrics, Department of Internal Medicine, Yonsei University College of Medicine, 50–1 Yonsei–ro, Seodaemun–gu, Seoul, 03722, Republic of Korea; Yonsei Institute for Digital Health, Yonsei University, 50–1 Yonsei–ro, Seodaemun–gu, Seoul, 03722, Republic of Korea
3
days
Inpatient outcomes of diabetic ketoacidosis complicating pancreatic cancer: a national inpatient sample analysis
AuthorsRushi Shah; Tanisha Vora
AffiliationsDepartment of Internal Medicine, Trinity Health Oakland / Wayne State University School of Medicine, Pontiac, Michigan, USA
84
days
Comparative effectiveness of sodium–glucose cotransporter-2 versus dipeptidyl peptidase-4 inhibitors on all-cause mortality in type 2 diabetes: a multinational propensity score–matched cohort study
AuthorsChing-Yu Li; Chih-Li Lin; Hung-Wen Cheng; Gwo-Ping Jong
AffiliationsInstitute of Medicine, Chung Shan Medical University, Taichung, Taiwan; Division of Cardiology, Department of Internal Medicine, Chung Shan Medical University Hospital, Taichung, Taiwan; Department of Pharmacy, Chung Shan Medical University Hospital, Taichung, Taiwan
45
days
Association between the glycemic risk index and peripheral atherosclerosis in hospitalized patients with type 2 diabetes: a cross-sectional study
AuthorsLi Ruopu; Cheng Dihe; Chen Yan
AffiliationsDepartment of Endocrinology, The Second Hospital of Jilin University, Changchun, Jilin, China
42
days
Glucagon-like peptide-1 receptor agonists and risk of pancreaticobiliary cancers in patients with type 2 diabetes: a nationwide cohort study
AuthorsByeong Geun Song; Tae-Se Kim; Bong Seong Kim; Kyungdo Han; Byung-Hoon Min
AffiliationsDepartment of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea; Department of Statistics and Actuarial Science, Soongsil University, Seoul, South Korea
24
days
Two faces of autoimmune hyperinsulinemia: contrasting type B insulin resistance syndrome and exogenous insulin antibody syndrome
AuthorsHuajie Zou; Xin Zheng; Siyi Wu; Tong Jiang; Xiaomei Ma; Ying Bai; Yuhong Li; Zilan Ma; Qiang Zhu; Shengmei Yang; Shenghua Ma; Ming Li; Ruixia Zhang
AffiliationsDepartment of Endocrinology and Metabolism, Affiliated Hospital of Qinghai University, Xining 810001, China; Department of Endocrinology, NHC Key Laboratory of Endocrinology, Peking Union Medical College Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing 100730, China; Department of Respiratory Medicine, Affiliated Hospital of Qinghai University, Xining 810001, China
33
days
Decreased risk of new-onset osteoporosis in patients with Type 2 diabetes on SGLT-2 inhibitors
AuthorsChih-Feng Chang; Wei-Yao Wang; Pei-Lun Liao; Chih-Jung Yeh; Gwo-Ping Jong
AffiliationsDivision of Cardiology, Department of Internal Medicine, Taichung Armed Force General Hospital, Taichung 41168, Taiwan; School of Public Health, Chung Shan Medical University, Taichung 40201, Taiwan; National Defense Medical University, Taipei, 114202, Taiwan; Department of Internal Medicine, Chung Shan Medical University Hospital, Taichung 40201, Taiwan; Institute of Medicine, Chung Shan Medical University, Taichung 40201, Taiwan; Department of Medical Research, Chung Shan Medical University Hospital, Taichung, Taiwan
55
days
CGM-based metrics and mortality in older adults living with type 2 diabetes on insulin therapy: a secondary analysis of the HYPOAGE study
AuthorsSarra Smati; Anne-Sophie Boureau; Pierre Gourdy; Béatrice Guyomarch; Cédric Annweiller; Claire Briet; Nathalie Cervantes; Laure de Decker; Isabelle Delabrière; Sophie Guyonnet; Marielle Joliveau; Rachel Litke; Pierre Morcel; Marc Paccalin; Alfred Penfornis; Pierre-Jean Saulnier; Samy Hadjadj; Bertrand Cariou
AffiliationsNantes Université, CHU Nantes, CNRS, INSERM, l’institut du thorax, Nantes, France; Nantes Université, CHU Nantes, INSERM, Department of Endocrinology, CIC 1413, l'institut du thorax, F-44000 Nantes, France; Nantes Université, CHU de Nantes, Pôle de Gérontologie Clinique, Nantes, France; CHU de Toulouse & UMR1297/I2MC, Université de Toulouse, Toulouse, France; CHU Nantes, Plateforme de Méthodologie et Biostatistique, F-44000 Nantes, France; Department of Geriatric Medicine and Memory Clinic, Research Center on Autonomy and Longevity, University Hospital, Angers, UPRES EA 4638, University of Angers, France; Département d'Endocrinologie, Diabétologie, Nutrition, CHU de Angers, Angers, France; Centre Hospitalier Sud Francilien, F-91100 Corbeil-Essonnes, France; CHU Lille, Geriatric Department, 59000 Lille, France; Gerontopole of Toulouse, Institute of Ageing, Toulouse University Hospital (CHU Toulouse), Toulouse, France; CHU de Poitiers, Pôle de gériatrie, Poitiers 86021, France; Université de Poitiers, INSERM, CHU Poitiers, Centre d'Investigation Clinique CIC 1402, Poitiers, France; Centre Hospitalier Sud Francilien, F-91100 Corbeil-Essonnes, Université Paris-Saclay, France
67
days
Persistent burden and management gaps of hypoglycemia in pediatric type 1 diabetes: insights from the Epi-GLUREDIA Study
AuthorsMaude Beckers; Antoine Harvengt; Gaetan de Valensart Schoenmaeckers; Dominique Beckers; Laure Boutsen; Thierry Mouraux; Inge Gies; Willem Staels; Jesse Vanbesien; Philippe A. Lysy
AffiliationsSpecialized Pediatrics Service, Cliniques universitaires Saint-Luc, Avenue Hippocrate 10, 1200 Brussels, Belgium; Pediatric Endocrinology and Diabetology, CHU UCL Namur, Rue Dr Gaston Therasse 1, 5530 Yvoir; Pediatric Department, Universitair Ziekenhuis Brussel, Laarbeeklaan 101, 1090 Brussels, Belgium; Vitality Research Group, Vrije Universiteit Brussel, Laarbeeklaan 103, 1090 Brussels; Beta Cell Neogenesis (BENE) research group, Genetics Reproduction and Development (GRAD), Vrije Universiteit Brussel, Laarbeeklaan 103, 1090 Brussels; UCLouvain, Institut de Recherche Expérimentale et Clinique, EDIN laboratory, Avenue Hippocrate 55, 1200 Brussels, Belgium
35
days
Impact of high intensity physical activity compared to routine counseling on renal function decline in patients with type 2 diabetes at high risk for kidney disease - the ACTIDIANE randomized controlled trial
AuthorsSamy Hadjadj; Stéphanie Ragot; Lisa Durocher; Edith Bigot-Corbel; Laurence Kessler; Igor Tauveron; Tiphaine Vidal-Trecan; Pierre Jean Saulnier; Pierre Gourdy; Myriam Moret; Vincent Rigalleau; Sophie Borot; Pierre Henri Ducluzeau; Cécile Ciangura; Nicolas Paquot; Anne Vambergue; Nicolas Chevalier; Claire Carette; Arnaud Monier; Philip Böhme; Alfred Pernfornis; Bruno Verges; Pierre Morcel; Jean François Gautier; Jean-Michel Halimi; Patrick Henry; Michel Marre; André Scheen; Martine Duclos; Laurent Bosquet; Bertrand Cariou
Affiliationsl’institut du thorax, Nantes Université, CHU Nantes, CNRS, INSERM, Nantes, France; Nantes Université, CHU Nantes, INSERM, Department of Endocrinology, CIC 1413, l'institut du thorax, F-44000 Nantes, France; University of Poitiers, INSERM, CHU Poitiers, Clinical Investigation Center CIC 1402, Poitiers, France; CHU Nantes, Department of Biology, F-44000 Nantes, France; Department of diabetology, University Hospital of Strasbourg, Inserm UMR 1260, University of Strasbourg, France; Endocrinologie Diabétologie, CHU Clermont Ferrand, 63000 Clermont Ferrand, France; Université Clermont Auvergne, 63000 Clermont Ferrand, France; Centre Universitaire du Diabète et de ses Complications, AP-HP, Hôpital Lariboisière, Paris, France; INSERM UMR-S1151, CNRS UMR-S8253, Immediab Lab, Institut Necker-Enfants Malades, Université Paris Cité, Paris, France; CHU de Toulouse & UMR1297/I2MC, Université de Toulouse, Toulouse, France; Hospices Civils de Lyon, Service d'endocrinologie, de diabétologie et des maladies métaboliques, Hôpital Louis Pradel, 69500 Bron, France; Endocrinology-Nutrition, CHU Bordeaux, Hospital Haut-Lévêque, Avenue de Magellan, 33604 Pessac, France; Université de Franche-Comté, CHU de Besançon, Service d'Endocrinologie-Diabétologie-Nutrition, Hôpital Minjoz, 3 boulevard Fleming, 25030 Besançon, France; Department of Endocrinology-Diabetology-Nutrition, CHU of Tours, 37000 Tours, France; Sorbonne Université, Assistance Publique-Hôpitaux de Paris, Institute of Cardiometabolism and Nutrition ICAN, Department of Diabetology, Pitié-Salpêtrière Hospital, Paris, France; CHU Liège, Diabetology, Nutrition and Metabolic diseases Unit, Departement of Medicine, avenue Hippocrate, 4000 Liège, Belgium; University of Liège, Belgium; Department of diabetes and nutrition, CHU Lille, 2 avenue Oscar Lambret - 59037 Lille, France & university of Lille, Lille, France; Service d’Endocrinologie, Diabétologie & Médecine de la Reproduction, Hôpital de l’Archet 2, 06202 Nice, France; Université Paris Cité; Department of Nutrition, Specialized Obesity Center, Hôpital Européen Georges Pompidou, Assistance Publique-Hôpitaux de Paris; INSERM CIC1418, F-75015 Paris, France; Diabétologie Endocrinologie, Centre hospitalier Louis Pasteur, 4 rue Claude Bernard, 28630 Le Coudray, France; Service d’endocrinologie, diabétologie, nutrition, CHRU Nancy, rue du Morvan, 54500 Vandoeuvre-lès-Nancy, France; Laboratoire Inserm U 1256, Ngere, faculté de médecine, maïeutique et métiers de la santé, Université de Lorraine, 9 avenue de la Forêt de Haye, 54500 Vandoeuvre-Les-Nancy, France; Centre Hospitalier Sud Francilien, F-91100 Corbeil-Essonnes, Université Paris-Saclay, France; Endocrinology-Diabetology department CHU Dijon, France, INSERM UMR 1231, Dijon, France; Université de Tours, INSERM UMR 1327, Tours, France; Department of cardiology, AP-HP, Hôpital Lariboisière, Paris, France; Clinique Ambroise Paré, Neuilly-sur-Seine 92200, France; Université Clermont Auvergne, INRAE, UNH, CHU Clermont-Ferrand, Service de Médecine du sport et des explorations fonctionnelles, Clermont-Ferrand, France; Université de Poitiers, Laboratoire MOVE (UR20296), Poitiers, France
Expert Matching · Case Demo
Turn Your Submission Goalsinto a Verifiable Journal Plan
Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.
Client
I work in environmental engineering and need an SCI paper published within three months. I have no grant funding or prominent co-author. Which journals could I target?
CrushSCI
Yes. We will first screen for feasibility against the 90-day deadline, then identify comparable papers without grant support or prominent co-authors. The final shortlist will prioritize research quality and journal scope.
- Suggested title
- Machine Learning and Life-Cycle Assessment for Predicting and Optimizing Carbon Emissions in Urban Wastewater Treatment
- Database shortlist
- Environmental Technology & Innovation
SampleLatest 5 valid paper samples from 2026
Average review96.4 days
Median77 days